OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!


2002 Individual Investigator Grant Recipient – Fergus Couch

Fergus Couch, Ph.D.
Mayo Clinic
Finding Genes Associated with Drug Resistance in Ovarian Cancer

Project Summary

Dr. Couch aims to develop a better understanding of the genetic events that cause resistance to taxol and platinum drugs, the standard chemotherapy combination treatment for ovarian cancer. The goal is to identify as many genes as possible that contribute to drug resistance. Other groups have studied resistance by identifying genes that are turned on or off in response to the chemotherapeutic drugs. However, few have tried to identify genes that normally play a role in the development and progression of tumors and which may also influence the response to the drugs. Dr. Couch has searched for these development and progression genes by studying a specific set of tumors that were collected during surgery, before the patients received therapy. By following these patients over time after they received their chemotherapy, he has identified tumors that recurred rapidly or were resistant to taxol and platinum therapy and those that did not recur for a long period and were sensitive to taxol and platinum therapy. It seems likely that many of these tumors were intrinsically resistant or sensitive to these agents. Such tumors form a unique resource for identifying the genes involved in progression and resistance. Dr. Couch has evidence to suggest that several of these genes are actually oncogenes, or cancer causing genes, that are amplified in copy number and cause the tumors to grow more rapidly. In the study, he will search for all sites of amplification in the tumors collected and will identify amplified genes that are statistically associated with resistance or sensitivity to platinum and taxol. Findings should lead to a better understanding of genes implicated in drug resistance and sensitivity.


Dr. Fergus Couch is a Professor of Laboratory Medicine and Pathology at the Mayo Clinic in Rochester, MN.

This grant is awarded in honor of Lois Kogen and has been partially funded by loving contributions from her friends and family. This grant has also been made possible by the tremendous dedication of Alison Walsh through the sales of Just One Miracle Stationery.